Sleep Apnea and Neuroendocrine Function

Sleep Medicine Clinics

Volumn 2, Issue 2, 2007, Pages 225-236

  Liu, Peter Y ^a   Yee, Brendon J ^b   Phillips, Craig L ^c   Grunstein, Ronald R ^c  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CATECHOLAMINE; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DIENOGEST PLUS ESTRADIOL VALERATE; ESTRADIOL VALERATE; ESTROGEN; GROWTH HORMONE; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; PROLACTIN; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE ESTER; THYROID HORMONE;

ANDROGEN DEPRIVATION THERAPY; ANDROGEN THERAPY; AROUSAL; CLINICAL TRIAL; DRUG DOSE TITRATION; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; ENDOCRINE DISEASE; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGONADISM; INSOMNIA; MENOPAUSE; NEUROENDOCRINE SYSTEM; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REM SLEEP; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING;

EID: 51249088227     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2007.03.008     Document Type: Review

References (104)

1. Bixler E.O., Vgontzas A.N., Lin H.M., et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 163 3 Pt 1 (2001) 608-613
2. Tishler P.V., Larkin E.K., Schluchter M.D., et al. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 289 17 (2003) 2230-2237
3. Young T., Skatrud J., and Peppard P.E. Risk factors for obstructive sleep apnea in adults. JAMA 291 16 (2004) 2013-2016
4. Whittle A.T., Marshall I., Mortimore I.L., et al. Neck soft tissue and fat distribution: comparison between normal men and women by magnetic resonance imaging. Thorax 54 4 (1999) 323-328
5. Malhotra A., Huang Y., Fogel R.B., et al. The male predisposition to pharyngeal collapse: importance of airway length. Am J Respir Crit Care Med 166 10 (2002) 1388-1395
6. White D.P., Schneider B.K., Santen R.J., et al. Influence of testosterone on ventilation and chemosensitivity in male subjects. J Appl Physiol 59 5 (1985) 1452-1457
7. Cistulli P.A., Grunstein R.R., and Sullivan C.E. Effect of testosterone administration on upper airway collapsibility during sleep. Am J Respir Crit Care Med 149 2 Pt 1 (1994) 530-532
8. Jordan A.S., Catcheside P.G., Orr R.S., et al. Ventilatory decline after hypoxia and hypercapnia is not different between healthy young men and women. J Appl Physiol 88 1 (2000) 3-9
9. Zhou X.S., Shahabuddin S., Zahn B.R., et al. Effect of gender on the development of hypocapnic apnea/hypopnea during NREM sleep. J Appl Physiol 89 1 (2000) 192-199
10. Zhou X.S., Rowley J.A., Demirovic F., et al. Effect of testosterone on the apneic threshold in females during NREM sleep. J Appl Physiol 94 1 (2003) 101-107
11. Liu P.Y., Death A.K., and Handelsman D.J. Androgens and cardiovascular disease. Endocr Rev 24 3 (2003) 313-340
12. Sandblom R.E., Matsumoto A.M., Scoene R.B., et al. Obstructive sleep apnea induced by testosterone administration. N Engl J Med 308 (1983) 508-510
13. Matsumoto A., Sandblom R.E., Schoene R.B., et al. Testosterone replacement in hypogonadal men: effects on obstructive sleep apnea, respiratory drives and sleep. Clin Endocrinol (Oxf) 22 (1985) 713-721
14. Millman R.P., Kimmel P.L., Shore E.T., et al. Sleep apnea in hemodialysis patients: the lack of testosterone effect on its pathogenesis. Nephron 40 (1985) 407-410
15. Schneider B.K., Pickett C.K., Zwillich C.W., et al. Influence of testosterone on breathing during sleep. J Appl Physiol 61 (1986) 618-623
16. Snyder P.J., Peachey H., Hannoush P., et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 84 6 (1999) 1966-1972
17. Portier F., Portmann A., Czernichow P., et al. Evaluation of home versus laboratory polysomnography in the diagnosis of sleep apnea syndrome. Am J Respir Crit Care Med 162 3 Pt 1 (2000) 814-818
18. Liu P.Y., Yee B.J., Wishart S.M., et al. The short-term effects of high dose testosterone on sleep, breathing and function in older men. J Clin Endocrinol Metab 88 8 (2003) 3605-3613
19. Johnson M.W., Anch A.M., and Remmers J.E. Induction of the obstructive sleep apnea syndrome in a woman by exogenous androgen administration. Am Rev Respir Dis 129 6 (1984) 1023-1025
20. Dexter D.D., and Dovre E.J. Obstructive sleep apnea due to endogenous testosterone production in a woman. Mayo Clin Proc 73 3 (1998) 246-248
21. Fogel R.B., Malhotra A., Pillar G., et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 86 3 (2001) 1175-1180
22. Vgontzas A.N., Legro R.S., Bixler E.O., et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 86 2 (2001) 517-520
23. Tasali E., Van Cauter E., and Ehrmann D.A. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab 91 1 (2006) 36-42
24. Stewart D.A., Grunstein R.R., Berthon-Jones M., et al. Androgen blockade does not affect sleep-disordered breathing or chemosensitivity in men with obstructive sleep apnea. Am Rev Respir Dis 146 6 (1992) 1389-1393
25. Hirshkowitz M., Moore C.A., O'Connor S., et al. Androgen and sleep-related erections. J Psychosom Res 42 6 (1997) 541-546
26. Leibenluft E., Schmidt P.J., Turner E.H., et al. Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men. J Clin Endocrinol Metab 82 10 (1997) 3203-3207
27. Cunningham G.R., and Hirshkowitz M. Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men. J Clin Endocrinol Metab 80 6 (1995) 1934-1940
28. Kravitz H.M., Janssen I., Santoro N., et al. Relationship of day-to-day reproductive hormone levels to sleep in midlife women. Arch Intern Med 165 20 (2005) 2370-2376
29. Polo-Kantola P., Erkkola R., Irjala K., et al. Climacteric symptoms and sleep quality. Obstet Gynecol 94 2 (1999) 219-224
30. Moline M.L., Broch L., Zak R., et al. Sleep in women across the life cycle from adulthood through menopause. Sleep Med Rev 7 2 (2003) 155-177
31. Maasilta P., Bachour A., Teramo K., et al. Sleep-related disordered breathing during pregnancy in obese women. Chest 120 5 (2001) 1448-1454
32. Prodromakis E., Trakada G., Tsapanos V., et al. Arterial oxygen tension during sleep in the third trimester of pregnancy. Acta Obstet Gynecol Scand 83 2 (2004) 159-164
33. Young T., Finn L., Austin D., et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 167 9 (2003) 1181-1185
34. Shahar E., Redline S., Young T., et al. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 167 9 (2003) 1186-1192
35. Carskadon M.A., Bearpark H.M., Sharkey K.M., et al. Effects of menopause and nasal occlusion on breathing during sleep. Am J Respir Crit Care Med 155 1 (1997) 205-210
36. Gislason T., Benediktsdottir B., Bjornsson J.K., et al. Snoring, hypertension, and the sleep apnea syndrome. An epidemiologic survey of middle-aged women. Chest 103 4 (1993) 1147-1151
37. Burger H.G., Dudley E.C., Cui J., et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85 8 (2000) 2832-2838
38. Young T., Rabago D., Zgierska A., et al. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep 26 6 (2003) 667-672
39. Keefe D.L., Watson R., and Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 6 3 (1999) 196-200
40. Manber R., Kuo T.F., Cataldo N., et al. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep 26 2 (2003) 163-168
41. Saaresranta T., Aittokallio T., Polo-Kantola P., et al. Effect of medroxyprogesterone on inspiratory flow shapes during sleep in postmenopausal women. Respir Physiol Neurobiol 134 2 (2003) 131-143
42. Saaresranta T., Polo-Kantola P., Rauhala E., et al. Medroxyprogesterone in postmenopausal females with partial upper airway obstruction during sleep. Eur Respir J 18 6 (2001) 989-995
43. Cistulli P.A., Barnes D.J., Grunstein R.R., et al. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 49 7 (1994) 699-702
44. Pickett C.K., Regensteiner J.G., Woodard W.D., et al. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol 66 4 (1989) 1656-1661
45. Saletu-Zyhlarz G., Anderer P., Gruber G., et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res 12 3 (2003) 239-254
46. Schiff I., Regestein Q., Tulchinsky D., et al. Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA 242 22 (1979) 2405-2407
47. Polo-Kantola P., Rauhala E., Helenius H., et al. Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol 102 1 (2003) 68-75
48. Polo-Kantola P., Erkkola R., Irjala K., et al. Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil Steril 71 5 (1999) 873-880
49. Block A.J., Wynne J.W., Boysen P.G., et al. Menopause, medroxyprogesterone and breathing during sleep. Am J Med 70 3 (1981) 506-510
50. Montplaisir J., Lorrain J., Denesle R., et al. Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause 8 1 (2001) 10-16
51. Manson J.E., Hsia J., Johnson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349 6 (2003) 523-534
52. Anderson G.L., Limacher M., Assaf A.R., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 14 (2004) 1701-1712
53. Grunstein R.R., Handelsman D.J., Lawrence S.J., et al. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab 68 2 (1989) 352-358
54. Gambineri A., Pelusi C., and Pasquali R. Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. J Endocrinol Invest 26 6 (2003) 493-498
55. Meston N., Davies R.J., Mullins R., et al. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med 254 5 (2003) 447-454
56. Luboshitzky R., Lavie L., Shen-Orr Z., et al. Pituitary-gonadal function in men with obstructive sleep apnea. The effect of continuous positive airways pressure treatment. Neuroendocrinol Lett 24 6 (2003) 463-467
57. Luboshitzky R., Aviv A., Hefetz A., et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab 87 7 (2002) 3394-3398
58. Luboshitzky R., Lavie L., Shen-Orr Z., et al. Altered luteinizing hormone and testosterone secretion in middle-aged obese men with obstructive sleep apnea. Obes Res 13 4 (2005) 780-786
59. Bratel T., Wennlund A., and Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 93 1 (1999) 1-7
60. Netzer N.C., Eliasson A.H., and Strohl K.P. Women with sleep apnea have lower levels of sex hormones. Sleep Breath 7 1 (2003) 25-29
61. Herrmann B.L., Wessendorf T.E., Ajaj W., et al. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur J Endocrinol 151 3 (2004) 309-315
62. Grunstein R.R., Ho K.K., and Sullivan C.E. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Ann Intern Med 121 7 (1994) 478-483
63. Grunstein R.R., Ho K.Y., Berthon-Jones M., et al. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med 150 2 (1994) 496-502
64. Grunstein R.R., Ho K.Y., and Sullivan C.E. Sleep apnea in acromegaly. Ann Intern Med 115 7 (1991) 527-532
65. Gerard J.M., Garibaldi L., Myers S.E., et al. Sleep apnea in patients receiving growth hormone. Clin Pediatr (Phila) 36 6 (1997) 321-326
66. Peker Y., Svensson J., Hedner J., et al. Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy. Clin Endocrinol (Oxf) 65 1 (2006) 98-105
67. Schneider H.J., Oertel H., Murck H., et al. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement. Psychoneuroendocrinology 30 1 (2005) 29-37
68. Harsch I.A., Konturek P.C., Koebnick C., et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22 2 (2003) 251-257
69. Gianotti L., Pivetti S., Lanfranco F., et al. Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J Clin Endocrinol Metab 87 11 (2002) 5052-5057
70. Steiger A. Ghrelin and sleep-wake regulation. Am J Physiol Regul Integr Comp Physiol 292 1 (2007) R573-R574
71. Frieboes R.M., Murck H., Stalla G.K., et al. Enhanced slow wave sleep in patients with prolactinoma. J Clin Endocrinol Metab 83 8 (1998) 2706-2710
72. Spiegel K., Follenius M., Krieger J., et al. Prolactin secretion during sleep in obstructive sleep apnoea patients. J Sleep Res 4 1 (1995) 56-62
73. Bohlhalter S., Murck H., Holsboer F., et al. Cortisol enhances non-REM sleep and growth hormone secretion in elderly subjects. Neurobiol Aging 18 4 (1997) 423-429
74. Rosenow F., McCarthy V., and Caruso A.C. Sleep apnoea in endocrine diseases. J Sleep Res 7 1 (1998) 3-11
75. Cooper B.G., White J.E., Ashworth L.A., et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18 3 (1995) 172-179
76. Chin K., Shimizu K., Nakamura T., et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100 7 (1999) 706-712
77. Grunstein R.R., Stewart D.A., Lloyd H., et al. Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones. Sleep 19 10 (1996) 774-782
78. Lanfranco F., Gianotti L., Pivetti S., et al. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol (Oxf) 60 1 (2004) 41-48
79. Buckley T.M., and Schatzberg A.F. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90 5 (2005) 3106-3114
80. Antic V., Dulloo A., and Montani J.-P. Multiple mechanisms involved in obesity-induced hypertension. Heart Lung Circ 12 2 (2003) 84-93
81. Engeli S., and Sharma A.M. Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension. Curr Opin Cardiol 17 4 (2002) 355-359
82. Fletcher E.C. Physiological and genomic consequences of intermittent hypoxia. J Appl Physiol 90 4 (2001) 1600-1605
83. Kumar G.K., Rai V., Sharma S.D., et al. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 575 1 (2006) 229-239
84. Moller D.S., Lind P., Strunge B., et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 16 4 (2003) 274-280
85. Calhoun D.A., Nishizaka M.K., Zaman M.A., et al. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125 1 (2004) 112-117
86. Maillard D., Fineyre F., Dreyfuss D., et al. Pressure-heart rate responses to adrenergic stimulation and hormonal regulation in normotensive patients with obstructive sleep apnea. Am J Hypertens 10 1 (1997) 24-31
87. Saarelainen S., Hasan J., Siitonen S., et al. Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnoea. J Sleep Res 5 3 (1996) 181-185
88. Umlauf M.G., and Chasens E.R. Sleep disordered breathing and nocturnal polyuria: nocturia and enuresis. Sleep Med Rev 7 5 (2003) 403-411
89. Coy T.V., Dimsdale J.E., Ancoli-Israel S., et al. Sleep apnoea and sympathetic nervous system activity: a review. J Sleep Res 5 1 (1996) 42-50
90. Peled N., Greenberg A., Pillar G., et al. Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome. Am J Hypertens 11 11 Pt 1 (1998) 1284-1289
91. Elmasry A., Lindberg E., Hedner J., et al. Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study. Eur Respir J 19 3 (2002) 511-517
92. Waradekar N.V., Sinoway L.I., Zwillich C.W., et al. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153 4 Pt 1 (1996) 1333-1338
93. Narkiewicz K.M.D.P., Kato M.M.D., Phillips B.G.B.P., et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100 23 (1999) 2332-2335
94. Ziegler M.G., Mills P.J., Loredo J.S., et al. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 120 3 (2001) 887-893
95. Esler M., Straznicky N., Eikelis N., et al. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48 5 (2006) 787-796
96. Miller C.M., and Husain A.M. Should women with obstructive sleep apnea syndrome be screened for hypothyroidism?. Sleep Breath 7 4 (2003) 185-188
97. Kapur V.K., Koepsell T.D., deMaine J., et al. Association of hypothyroidism and obstructive sleep apnea. Am J Respir Crit Care Med 158 5 Pt 1 (1998) 1379-1383
98. Astrom C., Christensen L., Gjerris F., et al. Sleep in acromegaly before and after treatment with adenomectomy. Neuroendocrinology 53 4 (1991) 328-331
99. Rosenow F., Reuter S., Deuss U., et al. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin Endocrinol (Oxf) 45 5 (1996) 563-569
100. Astrom C., Pedersen S.A., and Lindholm J. The influence of growth hormone on sleep in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 33 4 (1990) 495-500
101. Shipley J.E., Schteingart D.E., Tandon R., et al. EEG sleep in Cushing's disease and Cushing's syndrome: comparison with patients with major depressive disorder. Biol Psychiatry 32 2 (1992) 146-155
102. Dunleavy D.L., Oswald I., Brown P., et al. Hyperthyroidism, sleep and growth hormone. Electroencephalogr Clin Neurophysiol 36 3 (1974) 259-263
103. Ruiz-Primo E., Jurado J.L., Solis H., et al. Polysomnographic effects of thyroid hormones primary myxedema. Electroencephalogr Clin Neurophysiol 53 5 (1982) 559-564
104. Saini J., Krieger J., Brandenberger G., et al. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 25 7 (1993) 375-381